mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education.
This report describes a population-based analysis of COVID-19 incidence among counties with relatively large percentages of persons belonging to five racial and ethnic minority groups.
This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic.
In 22 participating K-12 schools implementing multiple COVID-19 mitigation strategies, school-based SARS-CoV-2 secondary transmission was detected in two of 102 tested close contacts of 37 persons with COVID-19.
COVID-19 school-related cases among Florida students correlated with community incidence in the counties observed, and was highest in smaller counties, districts without mask requirements, and those that reopened earliest.
In a high community transmission setting in Salt Lake County, Utah, low school-associated transmission was observed. Mask adherence was high, but physical distancing of >=6 feet was not possible so classroom seats were a median of 3 ft apart.
This report describes how national COVID-19 vaccination coverage was lower in counties with some of the most socially vulnerable communities and higher in counties with some of the least socially vulnerable communities.
This report describes an analysis of two Connecticut skilled nursing facilities that found partial vaccination, >14 days after the first dose through 7 days after the second dose, with the Pfizer-BioNTech COVID-19 vaccine 63% effective against SARS-CoV-2 infection.
This report describes persons who received both doses of a two-dose COVID-19 vaccination series and the interval between the first and second dose among those who were vaccinated.
This report describes rates of opioid overdose deaths before, during, and after an 11-week stay-at-home order in Illinois during the COVID-19 pandemic.
This report describes the frequency of emergency department visits, hospitalizations, and outcomes associated with accidental ingestion of poisonous mushrooms.
This report describes the Advisory Committee on Immunization Practices' (ACIP's) interim recommendation for use of the Janssen COVID-19 vaccine for the prevention of COVID-19.
This report describes a reduction in the number of COVID-19 patients requiring mechanical ventilation following initiation of a national vaccination campaign in Israel.
This report describes detection of the B.1.351 variant in Zambia that establishes an epidemiologic linkage between COVID-19 outbreaks in Zambia and South Africa.